Case number 1:18-cv-01308
Insys Therapeutics, Inc. et al v. Teva Pharmaceuticals USA, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 9, 2022 | 16 | [SEALED] SO ORDERED, re (107 in 1:17-cv-01303-CFC) Stipulation of Dismissal, filed by Teva Pharmaceuticals USA, Inc. CASE CLOSED. Signed by Judge Colm F. Connolly on 11/9/2022.This order has been emailed to local counsel. Associated Cases: 1:17-cv-01303-CFC, 1:18-cv-00414-CFC, 1:18-cv-01308-CFC, 1:18-cv-01775-CFC(kmd) (Entered: 11/09/2022) (0) |
| Mar 31, 2022 | N/A | Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Chief Magistrate Judge Thynge for the purpose of exploring ADR. Pursuant to the Court's Standing Order No. 2022-2, dated March 14, 2022, "[u]nless otherwise directed by the Court, Magistrate Judges will no longer engage in alternative dispute resolution of patent and securities cases." See also 28 U.S.C. ยง 652(b). (Taylor, Daniel) |
| Jul 15, 2019 | N/A | Case Stayed (0) Docket Text: Case Stayed per the stay in lead case no. 17-1308-CFC. (nmf) |
| Feb 19, 2019 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The Oral Order (DI 58 in 17-1303; DI 24 in 18-414; DI 16 in 18-1308; and DI 12 in 18-1775) resetting the time for the teleconference on 2/26/19 to 11:00 am was docketed in error and was removed from the docket. The teleconference was rescheduled to 4/23/19 at 10:00 a.m. Associated Cases: 1:17-cv-01303-CFC, 1:18-cv-00414-CFC, 1:18-cv-01308-CFC, 1:18-cv-01775-CFC(cak) |
| Sep 27, 2018 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:17-cv-01303-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 17-1303-CFC ONLY. (nmf) |
| Sep 27, 2018 | 15 | Scheduling Order (6) Docket Text: CONSOLIDATION AND SCHEDULING ORDER: Teva Pharmaceutical Industries, Ltd. is dismissed. THESE CASES ARE CONSOLIDATED FOR ALL PURPOSES AND ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 17-1303-CFC. Joinder of Parties due by 9/27/2018. Claim Construction Opening Brief Served by 11/6/2018. Claim Construction Answering Brief Served by 12/3/2018. Claim Construction Reply Brief Served by 12/21/2018. Claim Construction Surreply Brief Served by 1/8/2019. Parties to File Joint Claim Construction Brief & Joint Appendix of Evidence by 1/11/2019. A Markman Hearing is set for 2/12/2019 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 9/9/2019. A Final Pretrial Conference is set for 9/23/2019 at 10:00 AM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 10/15/2019 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 9/26/2018. Associated Cases: 1:17-cv-01303-CFC, 1:18-cv-00414-CFC, 1:18-cv-01308-CFC(nmf) |
| Sep 24, 2018 | 14 | Stipulation (6) Docket Text: Joint STIPULATION and [Proposed] Order to Consolidate Actions and Dismiss Teva Pharmaceutical Industries Ltd. by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Ying, Jennifer) |
| Sep 19, 2018 | 13 | Answer to Counterclaim (9) Docket Text: ANSWER to [6] Answer to Complaint, Counterclaim -- Answer to Counterclaim -- by Insys Development Company, Inc., Insys Therapeutics, Inc..(Blumenfeld, Jack) |
| Sep 18, 2018 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Telephonic Scheduling Conference held on 9/18/2018. (Court Reporter V. Gunning.) Counsel to submit a revised stipulation regarding scheduling and consolidation to the Court. Associated Cases: 1:17-cv-01303-CFC, 1:18-cv-00414-CFC, 1:18-cv-01308-CFC(nmf) |
| Sep 17, 2018 | 12 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant Teva Pharmaceuticals USA, Inc.'s Initial Invalidity Contentions filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd..(Shaw, John) |
| Sep 13, 2018 | 11 | Order Setting Scheduling Conference (2) Docket Text: Order Setting Telephonic Scheduling Conference: A Scheduling Conference is set for 9/18/2018 at 02:00 PM before Judge Colm F. Connolly to discuss the parties' proposed modifications to the case schedule as outlined in the stipulation of September 11, 2018. Counsel for plaintiffs shall coordinate and initiate the call to chambers. Signed by Judge Colm F. Connolly on 9/13/2018. Associated Cases: 1:17-cv-01303-CFC, 1:18-cv-00414-CFC, 1:18-cv-01308-CFC(nmf) |
| Sep 12, 2018 | N/A | Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: Plaintiff's counsel to initiate the call. A Telephone Conference is set for 2/26/2019 at 10:00 AM Eastern Time before Judge Mary Pat Thynge to discuss the status of the matters and ADR. Ordered by Judge Mary Pat Thynge on 9/12/18. Associated Cases: 1:17-cv-01303-CFC, 1:18-cv-00414-CFC, 1:18-cv-01308-CFC(cak) |
| Sep 11, 2018 | 9 | Stipulation (5) Docket Text: STIPULATION [And [Proposed] Order To Consolidate Actions And Dismiss Teva Pharmaceutical Industries, Ltd by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) Modified on 9/11/2018 (mdb). |
| Aug 29, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Aug 29, 2018 | 6 | Answer to Complaint (18) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Insys Development Company, Inc., Insys Therapeutics, Inc. by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Aug 29, 2018 | 7 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Aug 29, 2018 | 8 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Teva Pharmaceuticals USA, Inc. for Teva Pharmaceutical Industries Ltd. filed by Teva Pharmaceutical Industries Ltd.. (Hoeschen, Nathan) |
| Aug 24, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Teva Pharmaceutical Industries Ltd. on 8/24/2018; Teva Pharmaceuticals USA, Inc. on 8/24/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (crb) |
| Aug 23, 2018 | 1 | Main Document (11) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2446245.) - filed by Insys Therapeutics, Inc., Insys Development Company, Inc. (Attachments: # (1) Exhibit A - H, # (2) Civil Cover Sheet)(crb) (Main Document 1 replaced on 8/27/2018) (nmg). |
| Aug 23, 2018 | 1 | Exhibit A - H (351) |
| Aug 23, 2018 | 1 | Civil Cover Sheet (1) |
| Aug 23, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (crb) |
| Aug 23, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 7/10/2018. Date of Expiration of Patent: See Attachment.Thirty Month Stay Deadline: 7/31/2020. (crb) |
| Aug 23, 2018 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,486,972 B2 ;8,486,973 B2 ;8,835,459 B2 ;8,835,460 B2 ;9,241,935 B2. (crb) |
| Aug 23, 2018 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Insys Therapeutics, Inc. for Insys Development Company, Inc. filed by Insys Development Company, Inc., Insys Therapeutics, Inc. (crb) |
| Aug 23, 2018 | 1 | Complaint* (1) |
